ABSTRACTS – ORAL PRESENTATIONS - AMCA, spol. s r.o.

use of BD FACS Canto II flow cytometer. Subsequently, the percentage of leukemic cells
in bone marrow was assessed using Infinicyt software.
The mean percent of blast cells in the bone marrow of patients with BCP-ALL on day 15
and 33 of treatment was 3.80% and 0.53%, respectively. In turn, in T-ALL patients, the
mean percent of blast cells on day 15 and 33 of treatment reached 18.94% and 3.46%,
respectively.
Our study demonstrates that the levels of MRD in patients with T-ALL both at day 15 and
33 of induction treatment are significantly higher (p